A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...

Funding will be specifically used to accelerate the clinical development of urcosimod (formerly called OK-101).

Neither corticosteroids nor corneal crosslinking improve outcomes when added to standard bacterial keratitis therapy.